neonat
intens
care
unit
outbreak
palivizumab
rapid
screen
test
respiratori
syncyti
viru
u
r
palivizumab
current
licens
prevent
respiratori
syncyti
viru
rsv
lower
respiratori
tract
diseas
infant
children
chronic
lung
diseas
histori
preterm
birth
haemodynam
signific
congenit
heart
diseas
routin
use
outbreak
neonat
intens
care
unit
nicu
current
recommend
report
outbreak
nicu
detect
screen
trial
rsv
infect
use
rapid
antigen
test
respistrip
eleven
preterm
infant
nicu
test
posit
rsv
januari
subsequ
test
remain
infant
nicu
reveal
two
addit
asymptomat
case
addit
precaut
crossinfect
palivizumab
prophylaxi
administ
remain
prematur
infant
two
day
treatment
rsv
detect
two
addit
infant
becom
symptomat
knowledg
largest
rsv
outbreak
nicu
identifi
earli
stage
rapid
test
effect
control
infect
control
measur
palivizumab
prophylaxi
respiratori
syncyti
viru
rsv
common
caus
bronchiol
pneumonia
infant
rsv
infect
sever
prematur
infant
preexist
cardiac
pulmonari
diseas
chronic
lung
diseas
cld
limit
antibodi
respons
reduc
concentr
passiv
acquir
matern
antibodi
neonat
preterm
neonat
highli
suscept
rsv
given
high
rate
mortal
morbid
preterm
infant
particularli
among
cld
prophylact
treatment
rsv
recommend
certain
situat
follow
exposur
palivizumab
humanis
monoclon
antibodi
direct
f
glycoprotein
rsv
palivizumab
current
licens
prevent
rsv
lower
respiratori
tract
diseas
infant
children
cld
histori
preterm
birth
haemodynam
signific
congenit
heart
diseas
given
monthli
inject
rsv
season
usual
continu
five
month
northern
hemispher
howev
routin
outbreak
use
neonat
intens
care
unit
nicu
current
recommend
report
outbreak
rsv
affect
hospitalis
infant
nicu
identifi
earli
stage
rapid
test
control
palivizumab
prophylaxi
infect
control
measur
nicu
refer
centr
central
turkey
serv
patient
annual
includ
extrem
low
birth
weight
neonat
nicu
span
two
floor
one
exclus
prematur
infant
section
incub
open
bed
although
total
capac
unit
nicu
provid
familycentr
care
parent
permit
visit
take
part
care
babi
render
infant
suscept
exposur
extern
pathogen
rsv
rsv
season
turkey
usual
octob
april
northern
central
region
novemb
april
southern
region
countri
juli
initi
screen
studi
search
case
rsv
infect
otherwis
overlook
determin
real
incid
rsv
infect
everi
two
week
infant
hospitalis
seven
day
respiratori
symptom
screen
use
respistrip
cori
bioconcept
gembloux
belgium
principl
pointofcar
immunochromatographi
test
nitrocellulos
membran
sensitis
monoclon
antibodi
direct
rsv
mobil
antirsv
monoclon
antibodi
conjug
colloid
gold
particl
sampl
contain
rsv
conjugatersv
complex
remain
bound
antirsv
antibodi
adsorb
onto
nitrocellulos
reveal
red
line
develop
strip
test
perform
accord
manufactur
instruct
nasopharyng
swab
obtain
place
tube
contain
salin
solut
agit
aliquot
mix
extract
buffer
stir
thoroughli
strip
insert
tube
incub
min
read
presenc
posit
control
line
posit
test
line
consid
posit
result
test
perform
primari
investig
ead
test
avail
work
hour
throughout
outbreak
period
box
respistrip
check
posit
control
includ
box
use
patient
case
found
juli
decemb
howev
earli
januari
screen
detect
rsv
posit
preterm
infant
day
follow
infant
nicu
screen
reveal
two
case
infant
initi
asymptomat
case
develop
respiratori
symptom
within
h
remain
prematur
infant
nicu
week
gestat
age
birth
given
palivizumab
prophylaxi
administ
im
mg
kg
within
hour
detect
index
case
diagnosi
rsv
subsequ
confirm
case
polymeras
chain
reaction
pcr
surveil
test
rsv
repeat
use
respistrip
everi
h
infect
infant
becam
neg
infant
test
neg
respistrip
test
becam
symptomat
followup
two
day
palivizumab
administr
rsv
detect
one
addit
infant
case
becom
symptomat
anoth
infant
case
whose
clinic
pictur
suggest
rsv
infect
test
neg
respistrip
subsequ
found
posit
pcr
besid
rsv
patient
test
pcr
influenza
b
parainfluenza
coronaviru
metapneumoviru
rhinoviru
screen
bacteri
sepsi
blood
cultur
addit
palivizumab
prophylaxi
posit
case
nurs
togeth
separ
section
unit
contact
precaut
institut
infect
control
measur
implement
includ
use
glove
gown
mask
healthcar
personnel
respiratori
symptom
also
screen
visitor
number
limit
unit
close
admiss
outbreak
subsid
chart
infect
infant
review
gestat
age
date
birth
birth
weight
sex
prersv
oxygen
need
record
along
clinic
outcom
median
age
birth
weight
patient
week
rang
g
rang
respect
rsvposit
infant
gestat
week
median
age
diagnosi
rang
day
patient
characterist
given
tabl
among
preterm
infant
diagnos
rsv
five
die
ten
infect
patient
treat
ribavirin
mgkg
day
except
one
receiv
combin
support
treatment
includ
salbutamol
caffein
budesonid
inhal
nitric
oxid
system
corticosteroid
clarithromycin
one
infant
mild
upper
respiratori
symptom
receiv
oxygen
without
medic
recov
within
day
patient
develop
acut
respiratori
distress
syndrom
ard
n
receiv
surfact
rescu
treatment
five
patient
die
median
treatment
durat
day
diagnosi
rsv
infect
gestat
age
infant
week
one
bacteri
sepsi
addit
rsv
infect
test
virus
neg
similar
clinic
cours
infant
die
ie
rapid
deterior
increas
oxygen
demand
develop
pneumonia
ard
suggest
death
associ
supersed
rsv
infect
protect
rate
palivizumab
overt
clinic
rsv
infect
case
two
case
develop
rsv
infect
implement
prevent
measur
administr
palivizumab
among
patient
test
posit
rsv
respistrip
test
posit
pcr
yield
posit
predict
valu
respistrip
sensit
specif
respistrip
could
determin
sinc
infant
test
neg
subsequ
test
pcr
knowledg
rsv
outbreak
experienc
unit
first
epidem
detect
nicu
rapid
antigen
screen
epidem
identifi
screen
infant
nicu
isol
symptomat
infect
infant
impos
strict
infect
control
measur
critic
import
seri
indic
palivizumab
prophylaxi
along
routin
infect
control
measur
may
prevent
spread
rsv
epidem
larg
unit
incub
period
rsv
day
viral
shed
may
last
four
week
viru
surviv
hard
surfac
h
remain
detect
min
cloth
paper
stethoscop
use
palivizumab
control
nosocomi
rsv
outbreak
previous
report
kurz
et
al
success
prevent
outbreak
rsv
nicu
follow
detect
case
halasa
et
al
describ
rsv
outbreak
involv
nine
infect
infant
standard
infect
control
measur
plu
administr
palivizumab
remain
infant
nicu
implement
new
case
detect
thereaft
abadesso
et
al
analys
two
rsv
outbreak
although
standard
infect
control
measur
effect
first
five
addit
infant
infect
singl
month
second
immunoprophylaxi
palivizumab
administ
infant
nicu
author
conclud
help
prevent
uncontrol
rsv
outbreak
nicu
cox
et
al
report
outbreak
rsv
involv
seven
prematur
infant
palivizumab
given
eight
highrisk
preterm
infant
addit
case
occur
fifteen
case
rsv
diagnos
nicu
involv
patient
age
week
gestat
prematur
infant
highli
suscept
rsv
diseas
smaller
airway
immun
system
immatur
low
level
matern
acquir
rsvspecif
antibodi
diagnosi
rsv
larg
base
clinic
find
also
base
viru
isol
detect
viral
antigen
viral
rna
demonstr
rise
serum
antibodi
combin
approach
use
respistrip
rsv
rapid
antigen
test
kit
requir
two
reagent
extract
buffer
immunostrip
two
incub
technic
easi
perform
fast
result
avail
within
min
accur
sensit
specif
cost
respistrip
much
lower
pcr
vs
per
patient
sinc
earli
detect
implement
infect
control
measur
import
outbreak
control
rapid
antigen
test
repres
accur
fast
practic
method
diagnosi
rsv
infect
one
infant
neg
respistrip
test
posit
rsv
pcr
remain
infant
neg
respistrip
test
develop
clinic
suspect
rsv
infect
although
test
pcr
therefor
believ
sensit
specif
respistrip
test
accept
howev
rememb
test
perform
might
affect
high
incid
diseas
outbreak
may
lower
use
routin
screen
unabl
identifi
index
case
unit
larg
number
rsvinfect
patient
outsiz
nicu
therefor
decid
give
palivizumab
remain
unaffect
highrisk
infant
nicu
even
though
routin
recommend
current
guidelin
also
implement
addit
measur
includ
isol
posit
case
contact
precaut
limit
visitor
closur
elect
admiss
difficult
distinguish
intervent
alter
cours
outbreak
howev
given
high
control
rate
studi
previou
experi
palivizumab
believ
palivizumab
contribut
favour
outcom
detect
rsv
two
addit
patient
within
h
administr
palivizumab
may
explain
falseneg
respistrip
test
screen
period
palivizumab
administr
ineffect
palivizumab
patient
object
assess
diseas
sever
perform
believ
two
case
develop
rsv
palivizumab
milder
diseas
eleven
infant
rsv
infect
develop
pneumonia
wherea
four
infant
includ
two
receiv
prophylaxi
apnoea
bradycardia
cough
major
clinic
find
atelectasi
hyperinfl
infiltr
common
radiolog
find
observ
rsvinfect
infant
studi
consist
previou
data
rsv
infect
suspect
presenc
symptom
particularli
highrisk
patient
rsv
season
prognosi
somewhat
unfavour
fatal
infect
may
seen
seven
patient
requir
mechan
ventil
five
clinic
radiolog
find
ard
die
sever
rsv
infect
result
ard
mortal
rate
report
literatur
seven
infant
intub
born
week
gestat
show
prematur
also
neg
affect
cours
diseas
conclus
neonatologist
consid
rsv
infect
potenti
caus
fatal
outbreak
nicu
respistrip
repres
feasibl
inexpens
easytoperform
fast
option
rapid
diagnosi
infect
symptomat
prematur
babi
particularli
rsv
season
believ
palivizumab
administr
safe
may
role
control
rsv
outbreak
nicu
studi
need
determin
exact
role
palivizumab
optim
control
nosocomi
rsv
outbreak
